Search
Vertex Pharmaceuticals Inc
VRTXAdd to Watchlist
468.035USD
+1.245+0.27%
Market hours （ET）Quotes delayed by 15 min
118.96BMarket Cap
27.53P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
TRIKAFTA
10.31B
86.15%
ALYFTREK
837.80M
7.00%
Other CF products
820.10M
6.85%
By RegionUSD
Name
Revenue
Proportion
United States
7.55B
63.06%
Europe
3.46B
28.91%
Other
992.40M
8.29%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
TRIKAFTA
10.31B
86.15%
ALYFTREK
837.80M
7.00%
Other CF products
820.10M
6.85%
